Results 1 to 10 of about 3,332 (192)

Confounding Effect of Hepatic Carboxylesterase 1 (CES1) Variability on Clopidogrel Oxidation. [PDF]

open access: yesMol Pharm
Clopidogrel, a frequently used prodrug, is converted to its active metabolite through the intermediate 2-oxo-clopidogrel by cytochrome P450 (CYP) enzymes, which accounts for only 5%-15% of its metabolism. Majority of the clopidogrel dose (85%-90%) is extensively hydrolyzed to its inactive metabolite, clopidogrel carboxylic acid by carboxylesterase 1 ...
Subash S   +8 more
europepmc   +3 more sources

Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairment. [PDF]

open access: yesFront Pharmacol
Pokladyuk A   +4 more
europepmc   +1 more source

Ester Prodrug NLRP3 Inflammasome Inhibitor NT-0796 is Brain Active due to Activation by Local Expression of Carboxylesterase-1. [PDF]

open access: yesACS Chem Neurosci
Digby Z   +8 more
europepmc   +1 more source

Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort. [PDF]

open access: yesSci Rep
Tan SSN   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy